Abstract
Obesity affects millions of people worldwide, constituting a public health problem associated with premature mortality. Agave fructans decrease fat mass, body and liver weight, and generate satiety in rodents. In the present study the effects of agave fructans on weight control, lipid profile, and physical tolerability were evaluated in obese people. Twenty-eight obese volunteers were randomly divided into two groups. In the first group, 96 mg/bw of agave fructans was administered for 12 weeks; in the second group, maltodextrin as a placebo was administered for 12 weeks. All participants consumed a low-calorie diet of 1500 kcal/day. Anthropometric and biochemical measurements were taken at baseline and at the end of the study. The body mass index (BMI) of the agave fructans treated group was reduced significantly from the baseline to the final measurements. Hip and waist circumferences decreased statistically in both groups. A decrease of 10% in total body fat was observed in the agave fructans treated group, resulting in a statistically significant difference in the final versus baseline measurements between the Agave fructans treated group and the placebo treated group. Triglycerides were reduced significantly in the agave fructans treated group. Glucose values did not change in either group. Agave fructans intake was safe and well tolerated throughout the study. The results showed that the ingestion of agave fructans enhanced the decrease in BMI, the decrease in total body fat, and the decrease in triglycerides in obese individuals who consume a low-calorie diet.
Similar content being viewed by others
References
Bellisari A (2008) Evolutionary origins of obesity. Obes Rev 9:165–180. https://doi.org/10.1111/j.1467-789X.2007.00392.x
Barrientos-Gutierrez T, Zepeda-Tello R, Rodrigues ER, Colchero-Aragones A, Rojas-Martõnez R, Lazcano-Ponce E, Hernandez-Avila M, Rivera-Dommarco J, Meza R (2017) Expected population weight and diabetes impact of the 1-peso-per-litre tax to sugar sweetened beverages in Mexico. PLoS One 12:e0176336. https://doi.org/10.1371/journal.pone.0176336.
Rucker D, Padwal R, Li SK, Curioni C, Lau DCW (2007) Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 335:1194–1199. https://doi.org/10.1136/bmj.39385.413113.25.
Higashikawa F, Noda M, Awaya T, Danshiitsoodol N, Matoba Y, Kumagai T, Sugiyama M (2016) Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial. Eur J Clin Nutr 70:582–587. https://doi.org/10.1038/ejcn.2016.17.
Lattimer JM, Haub MD (2010) Effects of dietary fiber and its components on metabolic health. Nutrients 2:1266–1289. https://doi.org/10.3390/nu2121266
Apolinário AC, De Lima Damasceno BPG, De Macêdo Beltrão NE, Pessoa A, Converti A, Da Silva JA (2014) Inulin-type fructans: a review on different aspects of biochemical and pharmaceutical technology. Carbohydr Polym 101:368–378. https://doi.org/10.1016/j.carbpol.2013.09.081
Roberfroid MB, Van Loo JAE, Gibson GR (1998) The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128:11–19. https://doi.org/10.1038/ejcn.2009.64
Lopez-Velazquez G, Parra-Ortiz M, De la Mora-De la Mora I et al (2015) Effects of fructans from Mexican agave in newborns fed with infant formula: a randomized controlled trial. Nutrients 7:8939–8951. https://doi.org/10.3390/nu7115442
Velázquez-Martínez J, González-Cervantes R, Hernández-Gallegos M, Mendiola R, Aparicio A, Ocampo M (2014) Prebiotic potential of Agave angustifolia Haw Fructans with different degrees of polymerization. Molecules 19:12660–12675. https://doi.org/10.3390/molecules190812660
Roberfroid M, Gibson GR, Hoyles L et al (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104:S1–S63. https://doi.org/10.1017/S0007114510003363
Franco-Robles E, López MG (2015) Implication of fructans in health: immunomodulatory and antioxidant mechanisms. Sci World J 2015:15. https://doi.org/10.1155/2015/289267
Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90:1236–1243. https://doi.org/10.3945/ajcn.2009.28095
Alonso-Castro AJ, Domínguez F, Zapata-Morales JR, Carranza-Álvarez C (2015) Plants used in the traditional medicine of Mesoamerica (Mexico and central America) and the Caribbean for the treatment of obesity. J Ethnopharmacol 175:335–345. https://doi.org/10.1016/j.jep.2015.09.029
Livingston Iii DP, Hincha DK, Heyer AG, Livingston DP (2007) The relationship of fructan to abiotic stress tolerance in plants. In: Norio S, Noureddine B, Shuichi O (eds) Recent advances in fructooligosaccharides research. Res Signpost 661:181–199
Gomez E, Tuohy KM, Gibson GR, Klinder A, Costabile A (2010) In vitro evaluation of the fermentation properties and potential prebiotic activity of agave fructans. J Appl Microbiol 108:2114–2121. https://doi.org/10.1111/j.1365-2672.2009.04617.x
Ramnani P, Costabile A, Bustillo AGR, Gibson GR (2015) A randomised, double- blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects. J Nutr Sci 4:e10. https://doi.org/10.1017/jns.2014.68
Urías-Silvas JE, Cani PD, Delmée E, Neyrinck A, López MG, Delzenne NM (2008) Physiological effects of dietary fructans extracted from Agave tequilana Gto. and Dasylirion spp. Br J Nutr 99:254–261. https://doi.org/10.1017/S0007114507795338
Rendón-Huerta JA, Juárez-Flores B, Pinos-Rodríguez JM, Aguirre-Rivera JR, Delgado-Portales RE (2012) Effects of different sources of fructans on body weight, blood metabolites and fecal bacteria in normal and obese non-diabetic and diabetic rats. Plant Foods Hum Nutr 67:64–70. https://doi.org/10.1007/s11130-011-0266-9
Cani PD, Neyrinck AM, Maton N, Delzenne NM (2005) Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res 13:1000–1007. https://doi.org/10.1038/oby.2005.117
Ibero-Baraibar I, Perez-Cornago A, Ramirez MJ, Martinez JA, Zulet MA (2016) An increase in plasma homovanillic acid with cocoa extract consumption is associated with the alleviation of depressive symptoms in overweight or obese adults on an energy restricted diet in a randomized controlled trial. J Nutr 146:897S–904S. https://doi.org/10.3945/jn.115.222828
Márquez-Aguirre AL, Camacho-Ruiz RM, Arriaga-Alba M, Padilla-Camberos E, Kirchmayr MR, Blasco JL, González-Avila M (2013) Effects of Agave tequilana fructans with different degree of polymerization profiles on the body weight, blood lipids and count of fecal Lactobacilli/Bifidobacteria in obese mice. Food Funct 4:1237–1244. https://doi.org/10.1039/c3fo60083a
Flamm G, Glinsmann W, Kritchevsky D, Prosky L, Roberfroid M (2001) Inulin and Oligofructose as dietary fiber: a review of the evidence. Crit Rev Food Sci Nutr 41:353–362. https://doi.org/10.1080/20014091091841.
Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R (2006) Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55:1484–1490. https://doi.org/10.2337/db05-1360
Schaafsma G, Slavin JL (2015) Significance of inulin Fructans in the human diet. Compr Rev Food Sci Food Saf 14:37–47. https://doi.org/10.1111/1541-4337.12119
Kok N, Roberfroid M, Robert A, Delzenne N (1996) Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. Br J Nutr 76:881–890. https://doi.org/10.1079/BJN19960094
Delzenne NM, Kok NN (1999) Biochemical basis of oligofructose-induced hypolipidemia in animal models. J Nutr 129:1467S–1470S
Rutter MK, Meigs JB, Sullivan LM, D’Agostino RBS, Wilson PW (2005) Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham offspring study. Diabetes 54:3252–3257. https://doi.org/10.2337/diabetes.54.11.3252
Voruganti VS, Lopez-Alvarenga JC, Nath SD, Rainwater DL, Bauer R, Cole SA, MacCluer JW, Blangero J, Comuzzie AG (2008) Genetics of variation in HOMA-IR and cardiovascular risk factors in Mexican-Americans. J Mol Med 86:303–311. https://doi.org/10.1007/s00109-007-0273-3
Qu H-Q, Li Q, Rentfro AR, Fisher-Hoch SP, Mccormick JB (2011) The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS One 6:e21041. https://doi.org/10.1371/journal.pone.0021041
Parnell JA, Reimer RA (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89:1751–1759. https://doi.org/10.3945/ajcn.2009.27465
Kim S-H, Lee DH, Meyer D (2007) Supplementation of baby formula with native inulin has a prebiotic effect in formula-fed babies. Asia Pac J Clin Nutr 16:172–177
Mancilla-Margalli NA, Lopez MG (2006) Water-soluble carbohydrates and fructan structure patterns from agave and Dasylirion species. J Agric Food Chem 54:7832–7839. https://doi.org/10.1021/jf060354v
Acknowledgements
We thank Andrew Schmaus and Marcia M Craig from The University of Alberta for their contribution on this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1975 Helsinki declaration and its later amendments. Informed consent was obtained from all patients for being included in the study.
Rights and permissions
About this article
Cite this article
Padilla-Camberos, E., Barragán-Álvarez, C.P., Diaz-Martinez, N.E. et al. Effects of Agave fructans (Agave tequilana Weber var. azul) on Body Fat and Serum Lipids in Obesity. Plant Foods Hum Nutr 73, 34–39 (2018). https://doi.org/10.1007/s11130-018-0654-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11130-018-0654-5